Heart Failure with Reduced Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Reduced Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-01Clinical Trial Update: ASCs in Recently Diagnosed Non-ischemic Heart Failure [Phase 2]
A Phase 2 trial evaluating adipose-derived stem cells for non-ischemic heart failure with reduced ejection fraction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-04Clinical Trial Update: Effects of CRT Optimization as Assessed by Cardiac MR [NA]
A clinical trial evaluating optimization of cardiac resynchronization therapy (CRT) using cardiac magnetic resonance imaging was withdrawn, …
-
CLINICAL_TRIALS withdrawal · 2026-02-23Clinical Trial Update: Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy [Phase 2, Phase 3]
A clinical trial update regarding withdrawing treatment in heart failure patients who have recovered from tachycardia-induced cardiomyopathy…
-
CLINICAL_TRIALS withdrawal · 2026-01-26Clinical Trial Update: Magnesphere for Autonomic Alteration [NA]
The University of Oklahoma-sponsored clinical trial evaluating Magnesphere for autonomic alteration in heart failure with reduced ejection f…
-
CLINICAL_TRIALS withdrawal · 2025-08-17Clinical Trial Update: Evaluation of the HekaHeart Platform in Medication Management for Heart Failure Patients
This clinical trial registry entry indicates that Yale University's study evaluating the HekaHeart Platform for medication management in hea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-08-11Clinical Trial Update: Evaluation of Left Bundle Branch Area Pacing As A Rescue Strategy for Cardiac Resynchronization Therapy Non-Response [NA]
A clinical trial evaluating left bundle branch area pacing as a rescue strategy for patients with heart failure who do not respond to cardia…
-
CLINICAL_TRIALS withdrawal · 2025-05-20Clinical Trial Update: The STandard Versus ImAging SuBstrate Aided Ablation in Severe Left VEntricular Dysfunction VT. [NA]
A clinical trial evaluating ablation strategies for ventricular tachycardia in patients with severe left ventricular dysfunction has been wi…
-
CLINICAL_TRIALS withdrawal · 2024-11-20Clinical Trial Update: TRANSFORM Heart Failure with Reduced Ejection Fraction [NA]
The TRANSFORM trial for heart failure with reduced ejection fraction has been withdrawn, with no current status reported.
-
EMA withdrawal · 2024-09-30EMA Application withdrawn: Kinharto (omecamtiv mecarbil dihydrochloride hydrate) — Cytokinetics (Ireland) Limited
EMA has withdrawn its application for Kinharto (omecamtiv mecarbil dihydrochloride hydrate) for heart failure with systolic dysfunction.
-
CLINICAL_TRIALS withdrawal · 2024-05-20Clinical Trial Update: Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy. [Phase 4]
Phase 4 trial evaluating prophylactic lisinopril for anthracycline-induced cardiomyopathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-01Clinical Trial Update: Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure [NA]
A clinical trial evaluating email reminders to improve GDMT adherence for mineralocorticoid receptor antagonists in heart failure with reduc…
-
CLINICAL_TRIALS withdrawal · 2021-07-30Clinical Trial Update: Omecamtiv Mecarbil Post-trial Access Study [Phase 3]
Post-trial access study for omecamtiv mercabil (Omecamtiv Mecarbil) in chronic heart failure with reduced ejection fraction was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-10-11Clinical Trial Update: Comparing ARNI With ACE Inhibitor on Endothelial Function [Phase 4]
A Phase 4 trial comparing ARNI with ACE inhibitor on endothelial function in heart failure with reduced ejection fraction has been withdrawn…